The high expression of MSLN was significantly correlated with the decrease of overall survival at the histologic subtype of in ovarian cancer (Endometrioid, p=0.00033; Serous, p=0.0023) (Figures 3, B, C). The gene discussed is MSLN; the disease is ovarian carcinoma.